Thyroid dysfunction

Chairs

Paul C. Nathan, Hospital for Sick Children/University of Toronto, Toronto, Canada
Hanneke M. van Santen, University Medical Center Utrecht, Utrecht, the Netherlands

Coordinator

Sarah C. Clement, VU University Medical Center, Amsterdam, the Netherlands

Advisors

Leontien C.M. Kremer, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands and Emma Children’s Hospital, Amsterdam UMC, University of Amsterdam, the Netherlands
Roderick Skinner, Great North Children’s Hospital and Northern Institute of Cancer Research, Newcastle University, Newcastle upon Tyne, UK
Melissa M. Hudson, St. Jude Children’s Research Hospital, Memphis, United States
Renée L. Mulder, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands
Louis S. Constine,
Kevin C. Oeffinger, Duke University School of Medicine, Durham, United States

WG Leaders

Jill H. Simmons, Vanderbilt University Medical Center, Nashville, United States
Jonathan D. Wasserman, Hospital for Sick Children/University of Toronto, Toronto, Canada
F.A. Verburg, Erasmus Medical Center, Rotterdam, The Netherlands

WG members

E.K. Alexander,
Richa Arora,
E. Bardi,
E. Brignardello,
Wassim Chemaitilly, St. Jude Children’s Research Hospital, Memphis, United States
V. M. Drozd,
F. Felicetti,
E. Frey,
M. Goldfarb,
M.M. van den Heuvel – Eibrink, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands
S.A. Huang,
Neige Journy,
T.P. Links,
K. Lorenz,
N. Di Lorgi,
Sebastian J.C.M.M. Neggers, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands
E.J.M. Nieveen van Dijkum,
R.P. Peeters,
Maya Prasad,
S.A. Rivkees,
C.M. Ronckers, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands and Institute for Biostatistics and Registry Research, Brandenburg Medical School, Neuruppin, Germany
A.B. Schneider,
T. Wynn,